What is the recommended dose range for Terazosin in BPH treatment?

The recommended dose range for Terazosin in the treatment of benign prostatic hyperplasia (BPH) is 1 to 20 mg daily. Terazosin is an alpha-1 adrenergic antagonist that helps relax the muscles in the prostate and bladder neck, making it easier to urinate. This dosage range allows for flexibility in titrating the medication according to the patient's response and tolerance.

Starting with a lower dose is often advisable, and it can be gradually increased to within this range as necessary. The maximum dose of 20 mg per day accommodates the varied responses among patients, some of whom may require higher doses to achieve optimal symptom relief.

Lower dose ranges, such as those suggested in the other choices, do not encompass the full therapeutic potential of the medication for BPH, as they may not provide adequate symptom management for all patients. The range of 1 to 20 mg daily is thus the most suitable and comprehensive option for this condition.